HOME     CONTACT     BACK

 
 
 
THE PHARMA REVIEW (MAR 2010)

Indian Pharmaceutical Industry – The Challenges of The Product Patent Era

Dr. M.D. Nair

Introduction
In January 1995, the World Trade Organisation (WTO) was set up in Geneva to implement, regulate, administer and monitor the terms of the General Agreement on Tariffs and Trade (GATT) signed by the founding members in April 1994 at Marrakesh. The WTO today is the largest organization after the United Nations, with a membership of 154 countries involved in the management of a major multilateral treaty affecting all aspects of trade. India had as a part of the transitory dispensation under the TRIPS Agreement, ten years to implement a globally harmonized Intellectual Property Rights (IPR) protection system. The major component of TRIPS, the patent system was streamlined and implemented under Indian Patents Act 2005 from the beginning of that year. Since the Act has been in vogue for the last five years, it would be worthwhile to review the current status of its implementation and its impact on the Indian Pharmaceutical industry.

 

For full text of this article contact the publisher on info@kppub.com

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email: info@kppub.com / fpc@vsnl.com, Website: http://www.kppub.com

 
 
 

 Copyright 2008. KONGPOSH PUBLICATIONS Pvt. Ltd.